CANCER MedPage Today: U.S. Cancer Mortality Declined 35% Since 1991, AACR Report Shows (+++)

CANCER MedPage Today: U.S. Cancer Mortality Declined 35% Since 1991, AACR Report Shows https://www.medpagetoday.com/hematologyoncology/othercancers/123111?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_7QLXVM0XJAMHGubsZp_dwOWYCeateluaYaU5TSZd48_8h4rbcku719KyH6Yis5Y3NxtXlTYEhQFbJQeJxN7G77PehAw&_hsmi=440453853&utm_content=440453853&utm_source=hs_email The overall cancer mortality rate in the U.S. declined by 35% between 1991 and 2024, resulting in almost 5 million cancer deaths averted, according to the 2026 American Association for Cancer Research (AACR) Cancer Progress Report. That decline was largely driven by decreased smoking rates and an ensuing decline in lung cancer deaths, a trend that accelerated due to advances in early detection and treatment. (Bassett, 9/22) CIDRAP: Drug Shortages Disrupt Care At Leading US Cancer Centers https://www.cidrap.umn.edu/resilient-drug-supply/drug-shortages-disrupt-care-leading-us-cancer-centers?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-9ZeLpeWIIX6RXeyCbZAcbpA0RrKUrHrjkJQI9v_3xnMJ8h4U2aQ0_zQGgrCrFGBZUNmQbjevhZI54Ho4J4qME3ijdl8Q&_hsmi=440453853&utm_content=440453853&utm_source=hs_email All 31 leading cancer centers responding to a new survey reported shortages of at least one cancer drug, and nearly two-thirds said they resorted to mitigation strategies to keep patients on their recommended treatments. But in many cases, those mitigation strategies weren’t enough. Ninety percent of centers reported that treatment plans had to be modified because of drug shortages, creating additional insurance hurdles that may have delayed care. (Bergeson, 9/22) Modern Healthcare: Health Systems Expand Theranostics Programs For Cancer Treatment https://www.modernhealthcare.com/medical-devices/mh-theranostics-cancer-mayo-clinic-md-anderson/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_KLn9rovIN5cPG_vGOIRXJoDMFwgtES5uPmllzovScPlDD_0LVESi94PxQ9US2Lvvauid4aQXsYak8Cl8uQ1rOr6YKkQ&_hsmi=440453853&utm_content=440453853&utm_source=hs_email Medicine typically offers surgery, chemotherapy, radiotherapy and immunotherapy to treat cancer. Now, more providers are offering theranostics, an emerging targeted treatment approach. Major academic medical centers like Mayo Clinic, the University of Texas MD Anderson Cancer Center and UChicago Medicine have established theranostics programs, and community hospitals and outpatient cancer clinics are getting on board too. (Dubinsky, 9/22)